Dr. Scott R. Silva
Claim this profileThe James Graham Brown Cancer Center at University of Louisville
Area of expertise
Prostate Cancer
Scott R. Silva has run 3 trials for Prostate Cancer. Some of their research focus areas include:
Low Testosterone
Scott R. Silva has run 1 trial for Low Testosterone. Some of their research focus areas include:
Affiliated Hospitals
The James Graham Brown Cancer Center At University Of Louisville
UofL Health Medical Center Northeast
Clinical Trials Scott R. Silva is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting
0 awards
Phase 2
More about Scott R. Silva
Clinical Trial Related
7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Scott R. Silva has experience with
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Abiraterone
- Bicalutamide
- Degarelix
- Docetaxel
Breakdown of trials Scott R. Silva has run
Prostate Cancer
Low Testosterone
Renal Cell Carcinoma
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott R. Silva specialize in?
Scott R. Silva focuses on Prostate Cancer and Low Testosterone. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Scott R. Silva currently recruiting for clinical trials?
Yes, Scott R. Silva is currently recruiting for 3 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Scott R. Silva has studied deeply?
Yes, Scott R. Silva has studied treatments such as Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Abiraterone.
What is the best way to schedule an appointment with Scott R. Silva?
Apply for one of the trials that Scott R. Silva is conducting.
What is the office address of Scott R. Silva?
The office of Scott R. Silva is located at: The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky 40202 United States. This is the address for their practice at the The James Graham Brown Cancer Center at University of Louisville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.